TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.19, sa.3, ss.336-342, 2022 (ESCI)
Objectives: Drugs that inhibit the reuptake of serotonin, norepinephrine, and/or dopamine are widely used for treating depressive disorders and have emerged as effective drugs for neuropathic pain. They have no substantial anti-nociceptive effects but are considered, with gabapentin/ pregabalin, first-line drugs for neuropathic pain.